The US Supreme Court on Monday rejected a series of appeals from several of the nation's largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. https://t.co/R8kiPkRZro ...

The US Supreme Court let stand a $194 million award against Eli Lilly & Co. in a whistleblower suit accusing the company of engaging in Medicaid fraud by misreporting its drug prices. https://t.co/Y528sPoVFc ...

Merck & Co. has kicked off an investment-grade bond sale to help finance its $6.7 billion acquisition of Terns Pharmaceuticals Inc. https://t.co/nD6R0PSeo1 ...

Shares tumbled premarket after the drugmaker said a late-stage clinical trial of a skin cancer medication fell short of its target. https://t.co/jyRLmvCSUk ...

Big Pharma is pouring money into developing new treatments with the use of AI, but the verdict is out on whether they’ll actually work https://t.co/e3Ds0qekGd ...

PolyPeptide shortlists private equity firms EQT and IDG in the next round of bidding for the drugmaker https://t.co/DLcyaynABV ...